Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest cognitive disorders Stories

2014-01-30 23:29:58

Caring for parents affected by dementia can be overwhelming for caregivers as it is often a journey filled with uncertainty, anger, sadness and guilt. A new book from Praeclarus Press, Somebody Stole My Iron, offers hope and practical suggestions for coping when a family member has dementia. Amarillo, TX (PRWEB) January 30, 2014 It is becoming increasingly common to find baby boomers caring for their aging parents in today’s society. Oftentimes families pull together their resources...

2014-01-30 23:27:24

Acuity Games is pleased to announce the creation of Total Recall, a memory game inspired by the standard Alzheimer’s MMSE examination. Pompton Plains, NJ (PRWEB) January 30, 2014 Brain games developer Acuity Games is pleased to announce the creation of Acuity Games:Total Recall, the 11th game in their growing line-up of brain health assessment-based brain games. Total Recall was inspired by the MMSE (mini mental-state examination) question that requires patients to repeat a list of...

2014-01-28 23:20:47

Alzheimer’s safety campaign continues to reach out to individuals in a variety of cultural communities (PRWEB) January 28, 2014 The Alzheimer Society of Ontario, in partnership with the Government of Ontario is expanding the groundbreaking Finding Your Way TM program, a multicultural safety awareness initiative for people with dementia who go missing or become lost. The program will help prevent people with dementia from “wandering” and going missing, and help caregivers and other...

2014-01-28 08:30:32

NEW YORK, Jan. 28, 2014 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation of Canada (ADDF-Canada) and The W. Garfield Weston Foundation today announced a new funding collaboration to support a clinical trial investigating the potential for hypertension drugs to slow Alzheimer's disease progression. The trial will be led by Dr. Sandra Black and the Toronto Dementia Research Alliance at the University of Toronto. (Logo:...

2014-01-24 08:24:25

Research to Focus on Repurposing Drugs for Alzheimer's Disease and Related Dementias NEW YORK, Jan. 24, 2014 /PRNewswire-USNewswire/ -- Today the Alzheimer's Drug Discovery Foundation (ADDF) and the Alzheimer's Society (UK) announced a new partnership that will provide funding for research in Alzheimer's disease and related dementias, with the goal of accelerating critical development programs and bringing new treatments to patients. The partnership intends to fund projects up to $1.5...

2014-01-22 08:29:18

TSX: AMF TORONTO, Jan. 22, 2014 /CNW/ - Amorfix Life Sciences Ltd. announced today that the Company has signed an agreement with a major global pharmaceutical company to use the human Alzheimer's disease diagnostic assay in phase 1 clinical studies. Amorfix has granted its collaborator access to its proprietary EP-AD assay technology and the Company will complete assay optimization and validation prior to using the assay as part of a clinical trial to investigate the effects...

2014-01-14 16:26:29

NAPLES, Fla., Jan. 14, 2014 /PRNewswire/ -- Terracina Grand, a premier senior living community, today announced that the groundbreaking ceremony for its new two-story memory care community will take place on Wednesday, Jan. 15, 2014, adjacent to the existing property, near the corner of Davis Boulevard and County Barn Road in Naples. To commemorate the groundbreaking expansion of memory care at Terracina Grand, all event attendees will have a $25 donation made in their name to the...

SAGE Test Helps Spot Early Alzheimer's
2014-01-13 10:54:07

[ Watch The Video: Self-Administered Test Helps Spot Early Alzheimer’s ] The Ohio State University Wexner Medical Center The Self-Administered Gerocognitive Examination (SAGE test), which takes less than 15 minutes to complete, is a reliable tool for evaluating cognitive abilities. Findings by researchers at The Ohio State University Wexner Medical Center confirming the feasibility and efficiency of the tool for community screening large numbers of people are published in the...

2014-01-09 08:28:50

EMERYVILLE, Calif., Jan. 9, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. announced today that it has received $40 million in milestone payments from Forest Laboratories Holdings Limited (NYSE: FRX) for MDX-8704. MDX-8704 is a fixed dosed combination (FDC) of Namenda XR(®) (memantine HCl extended release capsules) and donepezil HCl being developed as a once daily therapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the United States. The...

2014-01-07 00:20:23

Early diagnosis keeps lives from unravelling says Alzheimer Society during Alzheimer Awareness Month TORONTO, Jan. 7, 2014 /CNW/ - As many as 50 per cent of Canadians with dementia are not diagnosed early enough,* losing precious time when care and support can make a tremendous difference in their quality of life and avert unnecessary crises for their families. That's why during Alzheimer Awareness Month, the Alzheimer Society is launching a new campaign, Early diagnosis keeps...